Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,879 | 98 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $401.12 | 14 | $0 (2024) |
| Novo Nordisk Inc | $339.61 | 24 | $0 (2024) |
| ABBVIE INC. | $273.00 | 12 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $187.64 | 11 | $0 (2022) |
| Lilly USA, LLC | $186.99 | 11 | $0 (2024) |
| SHIELD THERAPEUTICS INC | $84.11 | 2 | $0 (2024) |
| Amgen Inc. | $83.29 | 5 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $80.26 | 5 | $0 (2022) |
| Kowa Pharmaceuticals America, Inc. | $48.63 | 3 | $0 (2023) |
| Exact Sciences Corporation | $44.89 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $684.35 | 24 | ABBVIE INC. ($225.04) |
| 2023 | $188.20 | 8 | AstraZeneca Pharmaceuticals LP ($79.33) |
| 2022 | $1,007 | 66 | Novo Nordisk Inc ($290.14) |
All Payment Transactions
98 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: Inflammation | ||||||
| 09/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Diabetes | ||||||
| 09/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.08 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.02 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $47.05 | General |
| Category: Hematology | ||||||
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $53.51 | General |
| Category: Respiratory | ||||||
| 07/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $37.06 | General |
| Category: Hematology | ||||||
| 06/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: NEUROSCIENCE | ||||||
| 06/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Diabetes | ||||||
| 04/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.98 | General |
| Category: NEUROSCIENCE | ||||||
| 04/22/2024 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Pharma Products | ||||||
| 04/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Diabetes | ||||||
| 04/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Inflammation | ||||||
| 04/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: NEUROSCIENCE | ||||||
| 03/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: NEUROSCIENCE | ||||||
| 02/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Diabetes | ||||||
| 02/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $47.15 | General |
| Category: Respiratory | ||||||
| 02/05/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug), AIRSUPRA | Food and Beverage | In-kind items and services | $90.64 | General |
| Category: Respiratory | ||||||
| 01/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Diabetes | ||||||
| 11/07/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.03 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 10 | 417 | 788 | $98,113 | $49,286 |
| 2021 | 2 | 36 | 36 | $6,106 | $2,732 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 137 | 339 | $47,703 | $26,980 | 56.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 114 | 228 | $25,257 | $12,325 | 48.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 27 | 42 | $8,274 | $3,496 | 42.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 18 | $4,950 | $1,917 | 38.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 33 | $3,690 | $1,798 | 48.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $5,610 | $1,632 | 29.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 16 | 17 | $1,054 | $684.22 | 64.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 20 | 40 | $840.00 | $322.87 | 38.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 24 | 36 | $540.00 | $79.71 | 14.8% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2022 | 12 | 13 | $195.00 | $50.98 | 26.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 19 | 19 | $3,743 | $1,676 | 44.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 17 | $2,363 | $1,056 | 44.7% |
About Mary Parrish, APRN
Mary Parrish, APRN is a Primary Care healthcare provider based in Lake City, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/17/2021. The National Provider Identifier (NPI) number assigned to this provider is 1811667124.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mary Parrish, APRN has received a total of $1,879 in payments from pharmaceutical and medical device companies, with $684.35 received in 2024. These payments were reported across 98 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,879).
As a Medicare-enrolled provider, Parrish has provided services to 453 Medicare beneficiaries, totaling 824 services with total Medicare billing of $52,017. Data is available for 2 years (2021–2022), covering 12 distinct procedure/service records.
Practice Information
- Specialty Primary Care
- Other Specialties Family Medicine
- Location Lake City, FL
- Active Since 09/17/2021
- Last Updated 11/23/2021
- Taxonomy Code 363LP2300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1811667124
Products in Payments
- VRAYLAR (Drug) $241.45
- BREZTRI (Drug) $186.33
- Rybelsus (Drug) $175.39
- FARXIGA (Drug) $167.64
- Ozempic (Drug) $164.22
- MOUNJARO (Drug) $142.16
- STIOLTO RESPIMAT (Drug) $134.75
- ACCRUFER (Drug) $84.11
- SOLIQUA 100/33 (Biological) $61.10
- JARDIANCE (Drug) $52.89
- Aimovig (Biological) $49.30
- AIRSUPRA (Drug) $47.15
- Cologuard Collection Kit (Device) $44.89
- TRINTELLIX (Drug) $41.74
- NURTEC ODT (Drug) $41.18
- Otezla (Drug) $33.99
- Livalo (Drug) $33.31
- Kerendia (Drug) $32.70
- UBRELVY (Drug) $31.55
- TRULICITY (Drug) $27.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Primary Care Doctors in Lake City
Mrs. Elizabeth Newman, Arnp, ARNP
Primary Care — Payments: $6,713
Danielle Perry, Aprn, APRN
Primary Care — Payments: $1,023
Mr. Toney Graham, M.d, M.D
Primary Care — Payments: $853.91
Tracie Mitchem-Green, F.n.p, F.N.P
Primary Care
Ms. Casey Perry
Primary Care
Dr. Rene Zambrana, Dnp, Arnp, DNP, ARNP
Primary Care